A Guide to Understanding Reimbursement and Value-Based Care in the Military Health System.

Introduction: With the continued rise in the cost of U.S. health care, there is an increased emphasis on value-based care methodologies.

Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors.

Unlabelled: Autophagy inhibition is a potential therapeutic strategy in cancer, but it is unknown which tumors will benefit. The BRAF(V600E) mutation has been identified as important in pediatric central nervous system (CNS) tumors and is known to affect autophagy in other tumor types. We evaluated CNS tumor cells with BRAF(V600E) and found that mutant (but not wild-type) cells display high rates of induced autophagy, are sensitive to pharmacologic and genetic autophagy inhibition, and display synergy when the clinically used autophagy inhibitor chloroquine was combined with the RAF inhibitor vemurafenib or standard chemotherapeutics.